Associate Director, Clinical Operations
Cogent Biosciences
Kevin Moynihan is an Associate Director of Clinical Operations at Cogent Biosciences, a biotechnology company developing real solutions to treat genetically driven diseases. Kevin is the Clinical Operations Lead for the CGT9486-21-301 'Peak' Study for patients with locally advanced, unresectable, or metestatic gastrointestinal stomal tumors. Kevin brings > 15 years' experience as a Clinical Research Professional to Cogent Biosciences and is passionate about helping advance GIST research to help patients and families in need.